Congress sets date for hearing on Allergan-tribe deal
06-11-2017
Tribe ‘outraged’ at bill seeking to revoke IPR immunity
06-10-2017
Is the Allergan patent deal a misuse of sovereign immunity?
19-09-2017
uschools / iStockphoto.com
A US House of Representatives committee has begun a probe into Allergan’s patent deal with a Native American tribe.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
News stories up to a week old and feature articles on the day of publication are accessible with a BASIC FREE ACCOUNT.
Register here for free content, or subscribe for access to archive.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’; and for basic access to the latest news on the website and weekly email news alerts choose the 'BASIC FREE ACCOUNT' registration.
Allergan, Saint Mohawk Tribe, Restasis, patent, patent agreement, Native Americans, eye treatment, inter partes review, sovereign immunity, Mylan
